The troubles at Point Therapeutics continue as the company announced today that it made major cuts to its management team. On the chopping block were Donald Kiepert, Chairman and CEO; Richard Small, Senior Vice President and CFO; Michael Duffy, Senior Vice President and General Counsel; and Barry Jones, PhD., Senior Vice President and CSO. In May the Boston-based company announced that it would cut its work force by 60 percent after the FDA put a hold on Point's failed lead drug development program.
- see Point's release on the cuts